Skip to main content

Find Clinical Trials

Home
Conditions
Ann Arbor Stage III Mantle Cell Lymphoma

Clinical trial condition

Ann Arbor Stage III Mantle Cell Lymphoma

Explore clinical trials studying Ann Arbor Stage III Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Ann Arbor Stage III Mantle Cell Lymphoma trial results

Not Yet Recruiting

Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

NCT07444710

Conditions: Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma, Ann Arbor Stage IV Mantle Cell Lymphoma
Locations: Not specified

View Trial Details

Active, Not Recruiting

Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma

NCT02494700

Conditions: Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, +21 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details